Quick Answer
IMMUCELL CORP /DE/ reported Revenue (ASC 606) of $27.64 million for fiscal year 2025.
IMMUCELL CORP /DE/ Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $27.64M | +4.3% |
| 2024 | $26.49M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.51M | -8.4% | -8.4% |
| September 30, 2024 | $6.01M | — | — |
- IMMUCELL CORP /DE/ showed an increase of +4.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2024–2025 period, IMMUCELL CORP /DE/’s revenue (asc 606) has grown by 4.3% (from $26.49 million to $27.64 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: